Viewing Study NCT00153803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2026-04-10 @ 2:51 AM
Study NCT ID: NCT00153803
Status: COMPLETED
Last Update Posted: 2019-09-06
First Post: 2005-09-07
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Dartmouth-Hitchcock Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
None Non-small Cell Lung Cancer View
None NSCLC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Erlotinib View
None Tarceva View
None Web based View
None Stage III NSCLC View